… -cell responses requires the presentation of peptides derived from internalized antigen on
class I major histocompatibility complex molecules by dendritic cells … of vaccination is to deliver …

… either a novel vaccine consisting of autologous DCs pulsed with up to ten peptides (PEP-DC)…
or a sequential combination of a DC vaccine loaded with autologous oxidized tumor lysate (…

… cell-penetrating property of these peptides has been used to deliver antigenic peptide and
proteins into antigen-presenting cells including DCs for the development of vaccine delivery …

… We therefore conducted a phase I, clinical safety trial of a dendritic cell (DC)-based vaccination
… Participants were randomized to receive autologous DC-HIV-1 peptide vaccines either …

… dendritic cells (DC) derived by incubation of plastic-adherent peripheral blood mononuclear
cells (… for immunotherapy using vaccination and/or adoptive therapy with peptide-pulsed DC. …

… dendritic cell (DC)-based vaccines have not been explored for immunization against
tuberculosis. A gene-modified DC vaccine … AdAg85A-transduced DC vaccine (AdAg85/DC) …

… the induction of dendritic cell vaccine-induced antigenspecific T cells in advanced melanoma
… through CTL tolerization after peptide vaccination is avoided by peptide presentation on …

… with myelin peptides, it evokes an adaptive immune response directed to peptides of MBP. …
can be viewed as a DC vaccination and, like vaccination with the peptide in adjuvant, is a …

… of PBMCs to peptide reflects the presence of peptide-specific T cells, we measured the
frequency of CD8 + T cells binding MHC class I tetramers containing vaccine peptides (Fig. 1 and …

… to long peptide vaccines, vaccinations with soluble … T-cell responses and low specific CD8
+ T-cell responses. Relatively poor potency of protein-based vaccines to induce CD8 + T-cell …